- $2.24bn
- $2.12bn
- $198.07m
- 88
- 15
- 91
- 70
Annual income statement for Agilysys, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 141 | 161 | 137 | 163 | 198 |
| Cost of Revenue | |||||
| Gross Profit | 73.9 | 81 | 89.4 | 102 | 121 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 154 | 195 | 158 | 156 | 185 |
| Operating Profit | -13.1 | -34.1 | -21 | 6.32 | 12.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -12.9 | -33.9 | -21.2 | 6.51 | 15.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -12.9 | -34.1 | -21 | 6.48 | 14.6 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -13.2 | -34.1 | -21 | 6.48 | 14.6 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13.2 | -34.1 | -23.6 | 4.64 | 12.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.525 | -0.789 | -0.321 | 0.282 | 0.52 |